Tenaya Therapeutics
Founded Year
2016Stage
IPO | IPOTotal Raised
$248MDate of IPO
7/30/2021Market Cap
0.19BStock Price
2.62Missing: Tenaya Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Tenaya Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Tenaya Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Tenaya Therapeutics is included in 2 Expert Collections, including Biopharma Tech.
Biopharma Tech
15,535 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Regenerative Medicine
1,818 items
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
Tenaya Therapeutics Patents
Tenaya Therapeutics has filed 12 patents.
The 3 most popular patent topics include:
- Transcription factors
- Biotechnology
- Molecular biology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
4/28/2022 | 2/14/2023 | Grant |
Application Date | 4/28/2022 |
|---|---|
Grant Date | 2/14/2023 |
Title | |
Related Topics | |
Status | Grant |
Latest Tenaya Therapeutics News
Mar 8, 2023
Tenaya Therapeutics press release (NASDAQ: TNYA ): Q4 GAAP EPS of -$0.61 beats by $0.03. As of December 31, 2022, cash, cash equivalents and investments in marketable securities (current and noncurrent) were $204.2 million. Tenaya expects current cash, cash equivalents and investments in marketable securities (current and noncurrent) will be sufficient to fund the company into the first half of 2025. Recommended For You
Tenaya Therapeutics Frequently Asked Questions (FAQ)
When was Tenaya Therapeutics founded?
Tenaya Therapeutics was founded in 2016.
Where is Tenaya Therapeutics's headquarters?
Tenaya Therapeutics's headquarters is located at 171 Oyster Point Blvd, South San Francisco.
What is Tenaya Therapeutics's latest funding round?
Tenaya Therapeutics's latest funding round is IPO.
How much did Tenaya Therapeutics raise?
Tenaya Therapeutics raised a total of $248M.
Who are the investors of Tenaya Therapeutics?
Investors of Tenaya Therapeutics include The Column Group, Google Ventures, Casdin Capital, Fidelity Investments, RA Capital Management and 5 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.